BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moreira EG, Boll KM, Correia DG, Soares JF, Rigobello C, Maes M. Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1? Curr Neuropharmacol 2019;17:1004-20. [PMID: 30592255 DOI: 10.2174/1570159X17666181227164947] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Di Benedetto G, Burgaletto C, Bellanca CM, Munafò A, Bernardini R, Cantarella G. Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation. Cells 2022;11:2728. [DOI: 10.3390/cells11172728] [Reference Citation Analysis]
2 Lu ML, Ku WC, Syifa N, Hu SC, Chou CT, Wu YH, Kuo PH, Chen CH, Chen WJ, Wu TH. Developing a Sensitive Platform to Measure 5-Methyltetrahydrofolate in Subjects with MTHFR and PON1 Gene Polymorphisms. Nutrients 2022;14:3320. [PMID: 36014826 DOI: 10.3390/nu14163320] [Reference Citation Analysis]
3 Bliźniewska-Kowalska K, Gałecki P, Su KP, Halaris A, Szemraj J, Gałecka M. Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders. J Clin Med 2022;11:3321. [PMID: 35743392 DOI: 10.3390/jcm11123321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
4 Maes M, Barbosa DS, Almulla AF, Kanchanatawan B. A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine. Antioxidants 2022;11:803. [DOI: 10.3390/antiox11050803] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Berdowska I, Matusiewicz M, Krzystek-korpacka M. HDL Accessory Proteins in Parkinson’s Disease—Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics—A Review. Antioxidants 2022;11:524. [DOI: 10.3390/antiox11030524] [Reference Citation Analysis]
6 Michelin AP, Maes MHJ, Supasitthumrong T, Limotai C, Matsumoto AK, de Oliveira Semeão L, de Lima Pedrão JV, Moreira EG, Kanchanatawan B, Barbosa DS. Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis. WJP 2022;12:317-32. [DOI: 10.5498/wjp.v12.i2.317] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Michelin AP, Maes MHJ, Supasitthumrong T, Limotai C, Matsumoto AK, de Oliveira Semeão L, de Lima Pedrão JV, Moreira EG, Kanchanatawan B, Barbosa DS. Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis. World J Psychiatry 2022; 12(2): 308-322 [DOI: 10.5498/wjp.v12.i2.308] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Xin GX, Yee TP, Foon TS. Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Katrenčíková B, Vaváková M, Paduchová Z, Nagyová Z, Garaiova I, Muchová J, Ďuračková Z, Trebatická J. Oxidative Stress Markers and Antioxidant Enzymes in Children and Adolescents with Depressive Disorder and Impact of Omega-3 Fatty Acids in Randomised Clinical Trial. Antioxidants (Basel) 2021;10:1256. [PMID: 34439504 DOI: 10.3390/antiox10081256] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Milanesi M, Passamonti MM, Cappelli K, Minuti A, Palombo V, Sgorlon S, Capomaccio S, D'Andrea M, Trevisi E, Stefanon B, Williams JL, Ajmone-Marsan P. Genetic Regulation of Biomarkers as Stress Proxies in Dairy Cows. Genes (Basel) 2021;12:534. [PMID: 33917627 DOI: 10.3390/genes12040534] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Bryll A, Krzyściak W, Karcz P, Pilecki M, Śmierciak N, Szwajca M, Skalniak A, Popiela TJ. Determinants of Schizophrenia Endophenotypes Based on Neuroimaging and Biochemical Parameters. Biomedicines 2021;9:372. [PMID: 33916324 DOI: 10.3390/biomedicines9040372] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Xu Y, Wang K, Wang Q, Ma Y, Liu X. The Antioxidant Enzyme PON1: A Potential Prognostic Predictor of Acute Ischemic Stroke. Oxid Med Cell Longev 2021;2021:6677111. [PMID: 33628379 DOI: 10.1155/2021/6677111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
13 Maes M, Moraes JB, Bonifacio KL, Barbosa DS, Vargas HO, Michelin AP, Nunes SOV. Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach. Metab Brain Dis 2021;36:509-21. [PMID: 33411213 DOI: 10.1007/s11011-020-00656-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
14 Petrič B, Kunej T, Bavec A. A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease. OMICS 2021;25:38-51. [PMID: 33306925 DOI: 10.1089/omi.2020.0160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]